Saturday 17 October 2026 Export EVO’s income statement to Excel — free account

Evotec AG

EVO Healthcare Drug Manufacturers Specialty & Generic

Evotec AG’s revenue for fiscal 2025 (year ended December 2025) was $892.0 million, up 3.43% from fiscal 2024. In the quarter to June 2026, revenue fell 13.0%, EPS fell 328.9%, free cash flow fell 9,727.2% and total debt rose 5.48%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.

1.38 0.04 −2.82%

Follow EVO

Alert me

Market cap: $504.4M
P/E: 0.0×
Fwd P/E: −6.9×
Dividend yield: —
F-score: 5/9
Altman Z: 0.64
Beneish M: −2.62
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	—	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	—	1.03	1.23	1.55
P/FCF ratio Full definition →	—	0.00	0.00	0.00
P/Operating CF Full definition →	—	(193.71)	14.64	(16.30)
P/B ratio Full definition →	—	1.08	1.19	1.38
Price to Tangible BV Full definition →	—	1.92	1.90	2.21
EV/Sales Full definition →	—	0.97	1.19	1.91
EV/EBITDA Full definition →	—	0.00	0.00	0.00
EV/Operating CF Full definition →	—	45.06	(102.32)	(416.12)
EV/FCF Full definition →	—	(12.99)	(10.25)	(14.82)
Quick Ratio Full definition →	1.92	1.36	1.77	1.01
Current Ratio Full definition →	2.33	1.68	2.07	2.12
Net Debt/EBITDA Full definition →	0.00	1.20	(0.76)	(3.38)
Debt/Assets Full definition →	30.23%	18.22%	26.18%	21.87%
Debt/Equity Full definition →	0.72	0.43	0.55	0.48
Asset Turnover Full definition →	0.00	0.44	0.45	0.39
Operating CF/Net income Full definition →	0.00	0.03	4.71	1.57
Capex/Depreciation Full definition →	0.00	0.00	(0.13)	0.00
Research and Development Expense of Revenue Full definition →	—	6.44%	3.93%	5.32%
Selling, General and Administrative Expense of Revenue Full definition →	—	27.95%	17.66%	25.82%
Intangible Assets out of Total Assets Full definition →	0.19	0.19	0.18	0.17
Share Based Compensation of Revenue Full definition →	—	0.00%	0.00%	0.00%
Graham Net Nets Full definition →	—	(0.30)	(0.14)	(0.16)
Graham Number Full definition →	—	0.00	0.00	0.00
Earnings Yield Full definition →	—	(25.52%)	(10.71%)	(13.73%)
Free Cash Flow Yield Full definition →	—	(7.25%)	(9.47%)	(8.30%)
Revenue per Share Full definition →	—	0.52	0.83	0.54
Operating CF per Share Full definition →	0.00	(0.01)	0.21	(0.22)
Capex per Share Full definition →	0.00	(0.04)	(0.04)	(0.07)
Free Cash Flow per Share Full definition →	0.00	(0.05)	0.17	(0.30)
Cash per Share Full definition →	0.00	1.47	1.52	0.78
Shareholders Equity per Share Full definition →	0.00	2.31	2.59	2.63
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	0.00	2.31	2.59	2.63
Free Cash Flow Full definition →	(137.31)	(17.11)	59.89	(105.70)
Working Capital Full definition →	484.18	336.96	446.76	489.36
Capital Expenditures Full definition →	(12.71)	(12.53)	(14.83)	(26.56)
Net Current Asset Value Full definition →	(208.71)	(267.92)	(155.34)	(209.76)
EV/EBIT Full definition →	—	0.00	0.00	0.00
Capex to Sales Full definition →	0.00	0.07	0.05	0.14
Price to Operating Income Full definition →	—	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	145.38	181.83	184.26	227.35
Average Payables Full definition →	61.47	64.42	83.05	67.35
Average Inventory Full definition →	42.04	36.95	33.42	37.89
Average Assets Full definition →	1,941.40	1,984.10	2,004.34	2,130.60
Average Common Equity Full definition →	867.00	889.89	975.68	1,000.10

Show all line items

Columns are period end dates

Stockrow Weekly